Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov 15;192(10):1694-700.
doi: 10.1086/497148. Epub 2005 Oct 6.

Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS

Han-Zhu Qian  1 , Zhongmin Yang, Xiaoming Shi, Jianhua Gao, Cuiling Xu, Lan Wang, Kai Zhou, Yan Cui, Xiwen Zheng, Zunyou Wu, Fan Lu, Shenghan Lai, Sten H Vermund, Yiming Shao, Ning Wang
Affiliations

Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS

Han-Zhu Qian et al. J Infect Dis. .

Abstract

Background: Unsafe practices during illegal plasma donation in the late 1980s and early 1990s spread bloodborne infections in central China.

Methods: A cross-sectional survey of a random sample of 538 adult residents of 12 villages in rural Shanxi Province, where there had been an illegal commercial plasma-collection center, was conducted in 2003. Structured questionnaires were administered, and blood samples were tested for hepatitis C virus (HCV) antibodies.

Results: HCV seroprevalence rates were 8.2% in all subjects, 27.7% in former commercial plasma/blood donors, and 2.6% in nondonors. Selling blood or plasma was the strongest independent predictor of HCV seropositivity (odds ratio [OR], 14.4 [95% confidence interval {CI}, 7.1-31.6]). A history of blood transfusion was also independently associated with HCV seropositivity (OR, 8.3 [95% CI, 2.1-32.0]). Plasma donors had a higher risk of being HCV seropositive than did whole-blood donors (OR, 7.6 [95% CI, 2.9-20.9]), and female donors had a lower risk than did male donors (OR, 0.32 [95% CI, 0.12-0.80]). The strength of the association between selling blood and HCV seropositivity was weaker when plasma donors were excluded (OR, 8.0 vs. 14.4).

Conclusions: Unsafe practices during illegal plasma donation led to a high risk of HCV seropositivity for donors during the 1980s and 1990s. Failure to screen for HCV increased the risk of seropositivity for transfusion recipients during this same period. China has taken steps to halt illegal plasma collection and to improve blood-banking methods. However, there will be an ongoing challenge to care for patients with HCV infection, even as its incidence decreases.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest: none reported.

Figures

Figure 1
Figure 1
Screening and enrollment of subjects
See this image and copyright information in PMC

Comment in

References

    1. Koff RS, Hepatitis C. In: Infectious diseases. 2nd. Gorbach SL, Bartlett JG, Blacklow NR, editors. Philadelphia: W. B. Saunders; 1998. pp. 864–71.
    1. Liu CB. Epidemic and risk factors of viral hepatitis in general population in China. Zhongguo Gan Bing Za Zhi. 1998;6:67–70.
    1. Yuan YH, Hong KX, Liu SZ, et al. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World J Gastroenterol. 2004;10:1589–93. - PMC - PubMed
    1. Garten RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in southern China. Int J Epidemiol. 2004;33:182–8. - PubMed
    1. US Centers for Disease Control and Prevention. National Hepatitis C prevention strategy. [1 May 2005]. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/c/plan/HCV_infection.htm.

Publication types

Substances